Vertex Pharmaceuticals Incorporated (VRTX)
After hours:
| Previous Close | 467.97 |
| Open | 467.49 |
| Bid | 473.60 x 700 |
| Ask | 474.40 x 100 |
| Day's Range | 464.85 - 477.00 |
| 52 Week Range | 341.90 - 510.64 |
| Volume | |
| Avg. Volume | 1,092,698 |
| Market Cap | 122.895B |
| Beta (5Y Monthly) | 0.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.97 |
| Earnings Date | Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 512.55 |
Business WireVertex to Announce Third Quarter 2024 Financial Results on November 4th
BOSTON, October 10, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, November 4, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the "Vertex Pharmaceuticals Third Quarter 2024 Earnings Call."
Simply Wall St.October 2024's US Stocks That May Be Trading Below Estimated Fair Value
As the U.S. stock market continues its impressive rally, with the S&P 500 and Dow Jones Industrial Average reaching record highs, investors are increasingly focused on identifying opportunities that may be trading below their estimated fair value. In this buoyant market environment, a good stock is often characterized by strong fundamentals and potential for growth that hasn't yet been fully recognized by the broader market.
GuruFocus.comVertex Pharmaceuticals Inc (VRTX) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...
Vertex Pharmaceuticals Inc (VRTX) reports robust revenue growth and raises guidance, while addressing acquisition-related losses and strategic hurdles.
